Biosimilar Monoclonal Antibodies Market to Reach to USD 8.97 Billion by 2023
The global biosimlar monoclonal antibodies market is projected to grow at a CAGR of 42.8% over the period of 2017 to 2023 and reach to USD 8.97 billion by the end of 2023, states Infinium Global Research in its new report on global biosimilar monoclonal antibodies market. The report also identifies that with an expiry of several blockbuster drugs several biosimilar drugs to experience significant opportunities over the next few years. According to the report Patent expiration of biologics, innovative...
View full press release